85 related articles for article (PubMed ID: 21963865)
1. Searching for a therapy of creatine transporter deficiency: some effects of creatine ethyl ester in brain slices in vitro.
Adriano E; Garbati P; Damonte G; Salis A; Armirotti A; Balestrino M
Neuroscience; 2011 Dec; 199():386-93. PubMed ID: 21963865
[TBL] [Abstract][Full Text] [Related]
2. Effects of amide creatine derivatives in brain hippocampal slices, and their possible usefulness for curing creatine transporter deficiency.
Garbati P; Adriano E; Salis A; Ravera S; Damonte G; Millo E; Balestrino M
Neurochem Res; 2014 Jan; 39(1):37-45. PubMed ID: 24213972
[TBL] [Abstract][Full Text] [Related]
3. Response to creatine analogs in fibroblasts and patients with creatine transporter deficiency.
Fons C; Arias A; Sempere A; Póo P; Pineda M; Mas A; López-Sala A; Garcia-Villoria J; Vilaseca MA; Ozaez L; Lluch M; Artuch R; Campistol J; Ribes A
Mol Genet Metab; 2010 Mar; 99(3):296-9. PubMed ID: 19955008
[TBL] [Abstract][Full Text] [Related]
4. The creatine transporter mediates the uptake of creatine by brain tissue, but not the uptake of two creatine-derived compounds.
Lunardi G; Parodi A; Perasso L; Pohvozcheva AV; Scarrone S; Adriano E; Florio T; Gandolfo C; Cupello A; Burov SV; Balestrino M
Neuroscience; 2006 Nov; 142(4):991-7. PubMed ID: 16949212
[TBL] [Abstract][Full Text] [Related]
5. In vivo neuroprotection by a creatine-derived compound: phosphocreatine-Mg-complex acetate.
Perasso L; Adriano E; Ruggeri P; Burov SV; Gandolfo C; Balestrino M
Brain Res; 2009 Aug; 1285():158-63. PubMed ID: 19523930
[TBL] [Abstract][Full Text] [Related]
6. Di-acetyl creatine ethyl ester, a new creatine derivative for the possible treatment of creatine transporter deficiency.
Adriano E; Gulino M; Arkel M; Salis A; Damonte G; Liessi N; Millo E; Garbati P; Balestrino M
Neurosci Lett; 2018 Feb; 665():217-223. PubMed ID: 29229397
[TBL] [Abstract][Full Text] [Related]
7. Elevated plasma creatinine due to creatine ethyl ester use.
Velema MS; de Ronde W
Neth J Med; 2011 Feb; 69(2):79-81. PubMed ID: 21411845
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of new creatine fatty esters revealed dodecyl creatine ester as a promising drug candidate for the treatment of the creatine transporter deficiency.
Trotier-Faurion A; Dézard S; Taran F; Valayannopoulos V; de Lonlay P; Mabondzo A
J Med Chem; 2013 Jun; 56(12):5173-81. PubMed ID: 23697594
[TBL] [Abstract][Full Text] [Related]
9. Creatine salts provide neuroprotection even after partial impairment of the creatine transporter.
Adriano E; Garbati P; Salis A; Damonte G; Millo E; Balestrino M
Neuroscience; 2017 Jan; 340():299-307. PubMed ID: 26930002
[TBL] [Abstract][Full Text] [Related]
10. Qualitative in vitro NMR analysis of creatine ethyl ester pronutrient in human plasma.
Giese MW; Lecher CS
Int J Sports Med; 2009 Oct; 30(10):766-70. PubMed ID: 19585404
[TBL] [Abstract][Full Text] [Related]
11. Electrophysiology and biochemical analysis of cyclocreatine uptake and effect in hippocampal slices.
Enrico A; Patrizia G; Luisa P; Alessandro P; Gianluigi L; Carlo G; Maurizio B
J Integr Neurosci; 2013 Jun; 12(2):285-97. PubMed ID: 23869866
[TBL] [Abstract][Full Text] [Related]
12. pH-dependent stability of creatine ethyl ester: relevance to oral absorption.
Gufford BT; Ezell EL; Robinson DH; Miller DW; Miller NJ; Gu X; Vennerstrom JL
J Diet Suppl; 2013 Sep; 10(3):241-51. PubMed ID: 23957855
[TBL] [Abstract][Full Text] [Related]
13. Exocytotic release of creatine in rat brain.
Almeida LS; Salomons GS; Hogenboom F; Jakobs C; Schoffelmeer AN
Synapse; 2006 Aug; 60(2):118-23. PubMed ID: 16715490
[TBL] [Abstract][Full Text] [Related]
14. Effects of Delivering Guanidinoacetic Acid or Its Prodrug to the Neural Tissue: Possible Relevance for Creatine Transporter Deficiency.
Adriano E; Salis A; Damonte G; Millo E; Balestrino M
Brain Sci; 2022 Jan; 12(1):. PubMed ID: 35053827
[TBL] [Abstract][Full Text] [Related]
15. Congenital creatine transporter deficiency.
deGrauw TJ; Salomons GS; Cecil KM; Chuck G; Newmeyer A; Schapiro MB; Jakobs C
Neuropediatrics; 2002 Oct; 33(5):232-8. PubMed ID: 12536364
[TBL] [Abstract][Full Text] [Related]
16. [Cerebral creatine transporter deficiency: an infradiagnosed neurometabolic disease].
Campistol J; Arias-Dimas A; Poo P; Pineda M; Hoffman M; Vilaseca MA; Artuch R; Ribes A
Rev Neurol; 2007 Mar 16-31; 44(6):343-7. PubMed ID: 17385170
[TBL] [Abstract][Full Text] [Related]
17. Non-enzymatic hydrolysis of creatine ethyl ester.
Katseres NS; Reading DW; Shayya L; Dicesare JC; Purser GH
Biochem Biophys Res Commun; 2009 Aug; 386(2):363-7. PubMed ID: 19524547
[TBL] [Abstract][Full Text] [Related]
18. Creatine and creatine deficiency syndromes: biochemical and clinical aspects.
Nasrallah F; Feki M; Kaabachi N
Pediatr Neurol; 2010 Mar; 42(3):163-71. PubMed ID: 20159424
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous determination of guanidinoacetate, creatine and creatinine in urine and plasma by un-derivatized liquid chromatography-tandem mass spectrometry.
Carling RS; Hogg SL; Wood TC; Calvin J
Ann Clin Biochem; 2008 Nov; 45(Pt 6):575-84. PubMed ID: 18782816
[TBL] [Abstract][Full Text] [Related]
20. Creatine transporter deficiency: prevalence among patients with mental retardation and pitfalls in metabolite screening.
Arias A; Corbella M; Fons C; Sempere A; García-Villoria J; Ormazabal A; Poo P; Pineda M; Vilaseca MA; Campistol J; Briones P; Pàmpols T; Salomons GS; Ribes A; Artuch R
Clin Biochem; 2007 Nov; 40(16-17):1328-31. PubMed ID: 17825809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
